← FDA Drug Approvals (Drugs@FDA)

EVEROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2026-01-09

Drug application

FDA Application #

ANDA217216

Application type

Abbreviated New Drug Application (Generic)

Brand name

EVEROLIMUS

Generic name

EVEROLIMUS

Active ingredients

EVEROLIMUS

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

BIOCON PHARMA

Manufacturer

Biocon Pharma Inc.

First approval

2026-01-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown